NasdaqGS:INSMBiotechs
Insmed (INSM) Stock Looks Expensive On Sales But Strong On Returns
Insmed stock has surged over the past three years, yet the broader valuation checks currently point to a mixed picture rather than a clear bargain or clear overvaluation at the recent price of US$132.55. After a very sharp three year gain, investors are weighing that performance against valuation indicators that suggest the shares lean expensive on market multiples.
Insmed has delivered a very large return of roughly 4.8x over the past three years, which puts extra focus on whether the...